H. Lundbeck A/s
Clinical trials sponsored by H. Lundbeck A/s, explained in plain language.
-
New drug aims to give Parkinson's patients more 'Good' hours
Symptom relief Not yet recruitingThis study tests an experimental drug, Lu AF28996, in 150 adults with Parkinson's disease whose movement symptoms are not well controlled by their current medications. The goal is to see if adding this drug can increase the time they feel good and move well each day, without both…
Phase: PHASE2 • Sponsor: H. Lundbeck A/S • Aim: Symptom relief
Last updated May 17, 2026 03:39 UTC
-
New Parkinson's drug candidate enters safety testing in china
Symptom relief Not yet recruitingThis early-stage study will test a new drug called Lu AF28996 in 10 Chinese adults with Parkinson's disease. The main goal is to check if the drug is safe and how the body processes it. This is a first step to see if the drug might help control Parkinson's symptoms in the future.
Phase: PHASE1 • Sponsor: H. Lundbeck A/S • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC